Friday, November 10, 2017

News Recap:

Updated List of Physicians in British Columbia Currently Treating Hepatitis B and/or Hepatitis C. HepCBC has updated its list of Doctors in BC who treat HCV and HBV.

Direct-Acting Antiviral Therapy Outcomes in Canadian Chronic Hepatitis C Telemedicine Patients. Many of the 300,000 HCV-infected Canadians live in under-served and remote areas without access to HCV healthcare specialists. Telemedicine (TM) and advances in HCV management can facilitate linkage of these marginalized patients to healthcare

Liver Cancer:
Singapore’s Restalyst develops new method to improve liver cancer diagnosis. Singapore biomedical firm Restalyst has developed a new algorithm to detect liver cancer more accurately, improving the sensitivity to 90%. The new methodology looks at three factors: membrane bound protein ERBB3, AFP (alpha fetoprotein) and age of patient. It will detect and identify liver cancer more effectively, and better distinguish liver cancer from chronic hepatitis condition.

Mongolia’s liver cancer crisis: ‘No other country has a problem like this’. Cirrhosis and liver cancer cause 15% of all deaths in Mongolia. Now the government is waking up to the issue – and tackling the hepatitis that triggers it.

Did You Know?
Curing HCV Yields Long-Term Improvement in Quality of Life. Hepatitis C patients who attained sustained virologic response (SVR) with a direct-acting antiviral (DAA) drug maintained health improvements that enhanced their long-term quality of life, a new study shows.

HCV-related liver disease on the rise in women. Hepatitis C virus (HCV)-related complications are increasing among women, according to a national cohort study. This is because HCV-related mortality is lower in women than men, so they will live longer and the disease will have more time to cause problems. Yikes!!

Cherokee Nation screens more than 40,000 patients for hepatitis C. The Cherokee Nation has screened more than 40,000 tribal citizens for hepatitis C after becoming the first tribe in the country to launch an elimination project two years ago with the U.S. Centers for Disease Control and Prevention.

Worldwide 52 million children living with viral hepatitis. New data presented at this year’s World Hepatitis Summit in Sao Paulo, Brazil (1-3 November) show that 52 million children are living with viral hepatitis worldwide, compared to 2.1 million children living with HIV/AIDS.